eResearchTechnology, Inc. to Present at the J.P. Morgan Healthcare Conference on January 13, 2009
06 January 2009 - 7:07AM
PR Newswire (US)
PHILADELPHIA, Jan. 5 /PRNewswire-FirstCall/ -- eResearchTechnology,
Inc. (eRT), (NASDAQ:ERES), a leading provider of centralized ECG
and eClinical technology, ePRO and other services to the
pharmaceutical, biotechnology, medical device and related
industries, announced today that Dr. Michael J. McKelvey, the
Company's President and Chief Executive Officer, and Keith Schneck,
the Company's Chief Financial Officer, are scheduled to present at
the 27th Annual J.P. Morgan Healthcare Conference at 4:00 p.m. PST
on January 13, 2009 at the Westin St. Francis in San Francisco,
California. Interested parties may access the presentation by
visiting the Company's corporate website at http://www.ert.com/.
The webcast may also be accessed at
metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=ERES.
The webcast will be available via replay for 90 days. Based in
Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/)
is a provider of technology and services to the pharmaceutical,
biotechnology and medical device industries on a global basis. The
company is a market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements,
including but not limited to 2008 financial guidance, involve a
number of risks and uncertainties such as the company's ability to
obtain new contracts and accurately estimate net revenues due to
uncertain regulatory guidance, variability in size, scope and
duration of projects, and internal issues at the sponsoring client,
integration of acquisitions, competitive factors, technological
development, and market demand. As a result, actual results may
differ materially from any financial outlooks stated herein.
Further information on potential factors that could affect the
company's financial results can be found in the company's Reports
on Form 10-K and 10-Q filed with the Securities and Exchange
Commission. The company undertakes no obligation to publicly update
any forward-looking statement, whether as a result of new
information, future events, or otherwise. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Keith Schneck, CFO,
+1-215-972-0420, Web Site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Technology Inc. (MM) News Articles